The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Glbl E Regulatory News (JARE)

Share Price Information for Jpmorgan Glbl E (JARE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.82
Bid: 0.75
Ask: 0.89
Change: 0.00 (0.00%)
Spread: 0.14 (18.667%)
Open: 0.82
High: 0.82
Low: 0.82
Prev. Close: 0.82
JARE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Changes

20 Sep 2023 07:00

RNS Number : 9805M
JPMorgan Global Core Real Assets Ld
20 September 2023
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN GLOBAL CORE REAL ASSETS LIMITED

(the "Company" or "JARA")

 

Portfolio Changes

 

 

Legal Entity Identifier: 549300D8JHZTH6GI8F97

 

JARA has received notification of a further redemption receipt from its private real estate allocation. This redemption amounts to $1.5m and follows on from the previously received $3.7m redemption.

 

Across the Company's private real estate exposure, the overall occupancy is strong at 94.4%. The look-through debt profile remains healthy at 33% loan-to-value, with less than 1% of debt maturing for the remainder of 2023 and less than 15% maturing in 2024.

 

Leasing and re-leasing activities have also exhibited positive trends across the portfolio. JARA's U.S. private real estate exposure is on track to deliver over 10% net operating income growth this year, surpassing its growth in 2022 by over 4%. In the underlying private strategies, five recent Asia-Pacific leasing activities made during the second quarter of this year, applied rental rate increases ranging from 5% to 27%; averaging 17% higher than prior agreements.

 

The redemptions have reduced the private real estate allocation from 40% to 37% over the past year.  The portfolio management team will continue to monitor the market and make further adjustments as needed.

 

20 September 2023

 

 

Emma Lamb

JPMorgan Funds Limited - Company Secretary

Telephone 0207 742 4000

 

Notes

 

The Company aims to provide holders of the Ordinary Shares with a stable income and capital appreciation, measured on a constant currency basis, through exposure to a globally diversified portfolio of Core Real Assets in accordance with the Company's investment policy. The Company obtains exposure to Core Real Assets through various real asset strategies, namely: Global Infrastructure, Global Real Estate, Global Transport and Global Liquid Real Assets. J.P. Morgan's Alternative Solutions Group has the primary responsibility for managing the Company's portfolio.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUMZGMLNLLGFZM
Date   Source Headline
8th Apr 20247:00 amRNSMonthly Portfolio Update
3rd Apr 20246:25 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:04 pmRNSBlock listing Interim Review
2nd Apr 20245:00 pmRNSClosed Period Announcement
25th Mar 20244:33 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSQuarterly Net Asset Value and Portfolio Update
15th Mar 20245:46 pmRNSDirector/PDMR Shareholding
1st Mar 20249:53 amRNSTotal Voting Rights
19th Feb 20244:54 pmRNSTransaction in Own Shares
16th Feb 20244:53 pmRNSTransaction in Own Shares
13th Feb 20245:09 pmRNSTransaction in Own Shares
7th Feb 20245:00 pmRNSTransaction in Own Shares
7th Feb 20247:00 amRNSMonthly Portfolio Update
6th Feb 20244:51 pmRNSTransaction in Own Shares
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20244:57 pmRNSTransaction in Own Shares
2nd Feb 20244:47 pmRNSTransaction in Own Shares
18th Jan 20247:00 amRNSDividend Declaration
5th Jan 20247:00 amRNSMONTHLY PORTFOLIO UPDATE
2nd Jan 202411:39 amRNSTotal Voting Rights
21st Dec 20237:00 amRNSNet Asset Value(s)
19th Dec 20234:23 pmRNSTransaction in Own Shares
1st Dec 202312:17 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSHalf-year Report
21st Nov 20237:00 amRNSLive Webinar hosted by Capital Access Group
10th Nov 20237:00 amRNSMonthly Net Asset Value
8th Nov 20235:00 pmRNSTransaction in Own Shares
7th Nov 20235:01 pmRNSTransaction in Own Shares
3rd Nov 20235:11 pmRNSTransaction in Own Shares
2nd Nov 20235:18 pmRNSTransaction in Own Shares
1st Nov 20235:20 pmRNSTransaction in Own Shares
1st Nov 202311:13 amRNSTotal Voting Rights
31st Oct 20235:07 pmRNSTransaction in Own Shares
30th Oct 20234:13 pmRNSTransaction in Own Shares
27th Oct 20235:12 pmRNSTransaction in Own Shares
24th Oct 20235:18 pmRNSTransaction in Own Shares
18th Oct 20237:00 amRNSDividend Declaration
13th Oct 20234:48 pmRNSTransaction in Own Shares
12th Oct 20235:07 pmRNSTransaction in Own Shares
9th Oct 20235:03 pmRNSTransaction in Own Shares
6th Oct 20235:16 pmRNSTransaction in Own Shares
4th Oct 20237:00 amRNSMonthly Net Asset Value
3rd Oct 20235:19 pmRNSTransaction in Own Shares
2nd Oct 202311:35 amRNSTotal Voting Rights
28th Sep 20234:58 pmRNSTransaction in Own Shares
27th Sep 20235:28 pmRNSTransaction in Own Shares
26th Sep 20235:17 pmRNSTransaction in Own Shares
21st Sep 20239:27 amRNSClosed Period Notification
21st Sep 20237:00 amRNSQUARTERLY NET ASSET VALUE AND PORTFOLIO UPDATE
20th Sep 20235:02 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.